trending Market Intelligence /marketintelligence/en/news-insights/trending/fykxaulkwn-rmomfws1ija2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Soligenix closes $8M public offering


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Soligenix closes $8M public offering

Soligenix, Inc. said July 2 that it closed a public offering of shares and warrants to raise about $8 million in gross proceeds.

The Princeton, N.J.-based biopharmaceutical company issued 7,766,990 common shares and warrants to buy 3,106,796 shares at a combined price of $1.03 per share and warrant. The warrants are exercisable immediately at $2.25 per share and will expire 42 months from the date of issuance.

The underwriters partially exercised the overallotment to buy additional warrants to purchase 466,019 common shares.

Alliance Global Partners acted as sole book-running manager for the offering.